MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
GE Healthcare
GE Healthcare announces Class I recall of infant resuscitation kits
The FDA gave Class I status to GE Healthcare’s (NYSE:GE) recall of upgrade kits for some infant warmers over concerns that mislabeling in the kits may result in neonatal patients getting the wrong oxygen concentrations.
GE Healthcare delves into medical robots
Healthcare giant GE Healthcare (NYSE:GE) is taking a new approach to hospital robotics, aiming to leverage the "Industrial Internet" to develop automated systems that manage surgical tools.
Second Sight eyes $25M funding round | Wall Street Beat
Second Sight Medical registered with the SEC for a $25 million offering of equity, debt, options and warrants as it waits for the FDA to decide whether to give the green light to its "bionic eye" retinal implant.
The Sylmar, Calif.-based medical device company filed with the securities watchdog agency yesterday, saying it has yet to sell any of the $1,000 shares in the offering.
SpinalMotion closes 4th tranche of $15M round | Wall Street Beat
SpinalMotion closed the final tranche of a $15 million funding round that began in June 2011, according to a regulatory filing.
The Mountain View, Calif.-based medical device company raised a total of $15.1 million in the offering of debt, options and warrants from 15 unnamed investors, according to the filing.
Strong Q4 pushes GE Healthcare’s 2012 profits up 4%
GE Healthcare (NYSE:GE) posted single-digit profit growth last year driven by a strong 4th quarter that saw earnings top the $1 billion mark.
The Waukesha, Wis.-based division of industrial conglomerate General Electric posted 2012 profits of $2.92 billion on sales of $18.29 billion, up 1.1% and 4.2%, respectively, compared with 2011.
Medical device makers ink interoperability pledge
Nine medical device companies ranging from industry titans to small-cap movers inked a pledge to make the data generated by their devices available to patients, in a move aimed at ridding the healthcare system of unnecessary deaths by 2020.
GE Healthcare and Covidien team up for infant safety
Med-tech trends: The most talked about device makers in November 2012
Merit Medical to pay $167M for GE Healthcare’s Thomas Medical OEM vascular access biz
Merit Medical Systems (NSDQ:MMSI) agreed to pony up some $167 million for GE Healthcare‘s (NYSE:GE) Thomas Medical Products business, which makes an OEM maker of catheters used for vascular access.
GE Healthcare wins FDA nod for “breakthrough” FlightPlan for Liver
Healthcare giant GE Healthcare (NYSE:GE) won FDA 510(k) clearance for its liver embolization imaging technology, FlightPlan for Liver.
The system has been on the market in Europe, Latin America and Asia since last year and has already been installed in 10 countries, GE reported.